Transcriptional and epigenetic regulation of POMC gene expression

Journal of Molecular Endocrinology

Volumn 56, Issue 4, 2016, Pages T99-T112

  Drouin, Jacques ^a  

^a CLIN RESEARCH INSTITUTE OF MONTREAL   (Canada)

Author keywords

ACTH; Gene regulation; Hypothalamus; MSH; Pituitary; Transcription

Indexed keywords

GLUCOCORTICOID; GLUCOCORTICOID RECEPTOR; HELIX LOOP HELIX PROTEIN; ORPHAN NUCLEAR RECEPTOR; PROOPIOMELANOCORTIN; SMAD PROTEIN; STAT PROTEIN; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR PAX7; TRANSCRIPTION FACTOR PITX1; TRANSCRIPTION FACTOR PITX2; TRANSCRIPTION FACTOR TPIT; UNCLASSIFIED DRUG; CORTICOTROPIN RELEASING FACTOR; CYTOKINE; HOMEOBOX PROTEIN PITX1; HOMEODOMAIN PROTEIN; PAIRED BOX TRANSCRIPTION FACTOR; PROTEIN BINDING;

ACTH SECRETING CELL; CELL CYCLE REGULATION; CORTICOTROPIN DEFICIENCY; CUSHING DISEASE; EMBRYO DEVELOPMENT; ENHANCER REGION; EPIGENETICS; GENE EXPRESSION; GENE LOCUS; GENE MUTATION; GENETIC TRANSCRIPTION; HORMONAL REGULATION; HUMAN; HYPOPHYSIS FUNCTION; HYPOPHYSIS INTERMEDIATE LOBE; MELANOTROPH; NEGATIVE FEEDBACK; NONHUMAN; PRIORITY JOURNAL; REVIEW; SIGNAL TRANSDUCTION; TRANSCRIPTION REGULATION; ANIMAL; DRUG EFFECTS; GENE EXPRESSION REGULATION; GENETIC EPIGENESIS; GENETICS; HYPOPHYSIS; HYPOTHALAMUS; METABOLISM; PROMOTER REGION;

ANIMALS; CORTICOTROPIN-RELEASING HORMONE; CYTOKINES; EPIGENESIS, GENETIC; GENE EXPRESSION REGULATION; GLUCOCORTICOIDS; HOMEODOMAIN PROTEINS; HUMANS; HYPOTHALAMUS; PAIRED BOX TRANSCRIPTION FACTORS; PITUITARY ACTH HYPERSECRETION; PITUITARY GLAND; PRO-OPIOMELANOCORTIN; PROMOTER REGIONS, GENETIC; PROTEIN BINDING; SIGNAL TRANSDUCTION; STAT TRANSCRIPTION FACTORS; TRANSCRIPTION FACTORS; TRANSCRIPTION, GENETIC;

EID: 84973307702     PISSN: 09525041     EISSN: 14796813     Source Type: Journal    
DOI: 10.1530/JME-15-0289     Document Type: Review

References (101)

1. Akita S, Webster J, Ren SG, Takino H, Said J, Zand O & Melmed S 1995 Human and murine pituitary expression of leukemia inhibitory factor. Novel intrapituitary regulation of adrenocorticotropin hormone synthesis and secretion. Journal of Clinical Investigation 95 1288-1298. (doi:10.1172/JCI117779)
2. Bates SH, Stearns WH, Dundon TA, Schubert M, Tso AW, Wang Y, Banks AS, Lavery HJ, Haq AK, Maratos-Flier E, et al. 2003 STAT3 signalling is required for leptin regulation of energy balance but not reproduction. Nature 421 856-859. (doi:10.1038/ nature01388).
3. Batsche E, Desroches J, Bilodeau S, Gauthier Y & Drouin J 2005a Rb enhances p160/SRC coactivator-dependent activity of nuclear receptors and hormone responsiveness. Journal of Biological Chemistry 280 19746-19756. (doi:10.1074/jbc.M413428200)
4. Batsche E, Moschopoulos P, Desroches J, Bilodeau S & Drouin J 2005b Retinoblastoma and the related pocket protein p107 act as coactivators of NeuroD1 to enhance gene transcription. Journal of Biological Chemistry 280 16088-16095. (doi:10.1074/jbc. M413427200).
5. Bilodeau S, Vallette-Kasic S, Gauthier Y, Figarella-Branger D, Brue T, Berthelet F, Lacroix A, Batista D, Stratakis S, Hanson J, et al. 2006 Role of Brg1 and HDAC2 in GR trans-repression of pituitary POMC gene and misexpression in Cushing disease. Genes & Development 20 2871-2886. (doi:10.1101/gad.1444606)
6. Bilodeau S, Roussel-Gervais A & Drouin J 2009 Distinct developmental roles of cell cycle inhibitors p57Kip2 and p27Kip1 distinguish pituitary progenitor cell cycle exit from cell cycle re-entry of differentiated cells. Molecular and Cellular Biology 29 1895-1908. (doi:10.1128/MCB.01885-08)
7. Boutillier AL, Sassone-Corsi P & Loeffler JP 1991 The protooncogene c-fos is induced by corticotropin-releasing factor and stimulates proopiomelanocortin gene transcription in pituitary cels. Molecular Endocrinology 5 1301-1310. (doi:10.1210/mend-5-9-1301)
8. Boutillier AL, Monnier D, Lorang D, Lundblad JR, Roberts JL & Loeffler JP 1995 Corticotropin-releasing hormone stimulates proopiomelanocortin transcription by cFos-dependent and-independent pathways: characterization of an AP1 site in exon 1. Molecular Endocrinology 9 745-755. (doi:10.1210/mend.9.6.8592520)
9. Brue T, Quentien M, Khetchoumian K, Bensa M, Capo-Chichi J, Delemer B, Balsalobre A, Nassif C, Papadimitriou DT, Pagnier A, et al. 2014 Mutations in NFKB2 and potential genetic heterogeneity in patients with DAVID syndrome, having variable endocrine and immune deficiencies. BMC Medical Genetics 15 139. (doi:10.1186/ s12881-014-0139-9).
10. Budry L, Couture C, Balsalobre A & Drouin J 2011 The Ets factor Etv1 interacts with Tpit protein for pituitary pro-opiomelanocortin (POMC) gene transcription. Journal of Biological Chemistry 286 25387-25396. (doi:10.1074/jbc.M110.202788)
11. Budry L, Balsalobre A, Gauthier Y, Khetchoumian K, L'Honore A, Vallette S, Brue T, Figarella-Branger D, Meij B & Drouin J 2012 The selector gene Pax7 dictates alternate pituitary cell fates through its pioneer action on chromatin remodeling. Genes & Development 26 2299-2310. (doi:10.1101/gad.200436.112)
12. Bumaschny VF, de Souza FS, Lopez Leal RA, Santangelo AM, Baetscher M, Levi DH, Low MJ & Rubinstein M 2007 Transcriptional regulation of pituitary POMC is conserved at the vertebrate extremes despite great promoter sequence divergence. Molecular Endocrinology 21 2738-2749. (doi:10.1210/me.2006-0557)
13. Campos-Melo D, Galleguillos D, Sanchez N, Gysling K & Andres ME 2013 Nur transcription factors in stress and addiction. Frontiers in Molecular Neuroscience 6 44. (doi:10.3389/fnmol.2013.00044)
14. Charles MA, Suh H, Drouin J, Camper SA & Gage PJ 2005 PITX genes are required for cell survival and Lhx3 activation. Molecular Endocrinology 19 1893-1903. (doi:10.1210/me.2005-0052)
15. Chen K, Coonrod EM, Kumanovics A, Franks ZF, Durtschi JD, Margraf RL, Wu W, Heikal NM, Augustine NH, Ridge PG, et al. 2013 Germline mutations in NFKB2 implicate the noncanonical NF-kappaB pathway in the pathogenesis of common variable immunodeficiency. American Journal of Human Genetics 93 812-824. (doi:10.1016/j.ajhg.2013.09.009)
16. Coulon V, L'Honoré A, Ouimette JF, Dumontier É, van den Munckhof P & Drouin J 2007 A muscle-specific promoter directs Pitx3 gene expression in early muscle cells. Journal of Biological Chemistry 282 33192-33200. (doi:10.1074/jbc.M706119200)
17. Coupe B & Bouret SG 2013 Development of the hypothalamic melanocortin system. Frontiers in Endocrinology (Lausanne) 4 38. (doi:10.3389/fendo.2013.00038)
18. Couture C, Saveanu A, Barlier A, Baechler A, Wherett D, Houang Y, Lebouc Y, Fassnacht M, Maes D, Fluck C, et al. 2012 Phenotypic homogeneity and genotypic variability in a large series of congenital isolated ACTH deficiency patients with TPIT gene mutations. Journal of Clinical Endocrinology & Metabolism 97 486-495. (doi:10.1210/ jc.2011-1659)
19. de Souza FS, Santangelo AM, Bumaschny V, Avale ME, Smart JL, Low MJ & Rubinstein M 2005 Identification of neuronal enhancers of the proopiomelanocortin gene by transgenic mouse analysis and phylogenetic footprinting. Molecular and Cellular Biology 25 3076-3086. (doi:10.1128/MCB.25.8.3076-3086.2005)
20. de Souza FS, Nasif S, Lopez-Leal R, Levi DH, Low MJ & Rubinsten M 2011 The estrogen receptor alpha colocalizes with proopiomelanocortin in hypothalamic neurons and binds to a conserved motif present in the neuron-specific enhancer nPE2. European Journal of Pharmacology 660 181-187. (doi:10.1016/j.ejphar.2010.10.114)
21. Drouin J, Trifiro MA, Plante RK, Nemer M, Eriksson P & Wrange Ö 1989 Glucocorticoid receptor binding to a specific DNA sequence is required for hormone-dependent repression of pro-opiomelanocortin gene transcription. Molecular and Cellular Biology 9 5305-5314. (doi:10.1128/MCB.9.12.5305)
22. Drouin J, Sun YL, Chamberland M, Gauthier Y, De Léan A, Nemer M & Schmidt TJ 1993 Novel glucocorticoid receptor complex with DNA element of the hormone-repressed POMC gene. EMBO Journal 12 145-156.
23. Drouin J, Bilodeau S & Vallette-Kasic S 2007 Of old and new diseases: genetics of pituitary ACTH excess (Cushing) and deficiency. Clinical Genetics 72 175-182. (doi:10.1111/j.1399-0004.2007.00877.x)
24. Elkabes S, Loh YP, Nieburgs A & Wray S 1989 Prenatal ontogenesis of pro-opiomelanocortin in the mouse central nervous system and pituitary gland: an in situ hybridization and immunocytochemical study. Developmental Brain Research 46 85-95. (doi:10.1016/0165-3806(89)90145-4).
25. Gage PJ, Suh H & Camper SA 1999a The bicoid-related Pitx gene family in development. Mammalian Genome 10 197-200. (doi:10.1007/ s003359900970).
26. Gage PJ, Suh HY & Camper SA 1999b Dosage requirement of Pitx2 for development of multiple organs. Development 126 4643-4651.
27. Gagner J-P & Drouin J 1985 Opposite regulation of proopiomelanocortin gene transcription by glucocorticoids and CRH. Molecular and Cellular Endocrinology 40 25-32. (doi:10.1016/0303-7207(85)90154-6).
28. Gagner J-P & Drouin J 1987 Tissue-specific regulation of pituitary proopiomelanocortin gene transcription by corticotropin-releasing hormone, 3', 5'-cyclic adenosine monophosphate, and glucocorticoids. Molecular Endocrinology 1 677-682. (doi:10.1210/ mend-1-10-677).
29. Gali Ramamoorthy T, Begum G, Harno E & White A 2015 Developmental programming of hypothalamic neuronal circuits: impact on energy balance control. Frontiers in Neuroscience 9 126. (doi:10.3389/fnins.2015.00126)
30. Ge C, Che L, Ren J, Pandita RK, Lu J, Li K, Pandita TK & Du C 2015 BRUCE regulates DNA double-strand break response by promoting USP8 deubiquitination of BRIT1. PNAS 112 E1210-E1219. (doi:10.1073/pnas.1418335112)
31. Gee CE, Chen CLC, Roberts JL, Thompson R & Watson SJ 1983 Identification of pro-opiomelanocortin neurones in rat hypothalamus by in situ cDNA-mRNA hybridization. Nature 306 374-376. (doi:10.1038/306374a0)
32. Hammer GD, Fairchild-Huntress V & Low MJ 1990 Pituitary-specific and hormonally regulated gene expression directed by the rat proopiomelanocortin promoter in transgenic mice. Molecular Endocrinology 4 1689-1697. (doi:10.1210/mend-4-11-1689)
33. Hwang DY, Ardayfio P, Kang UJ, Semina EV & Kim KS 2003 Selective loss of dopaminergic neurons in the substantia nigra of Pitx3-deficient aphakia mice. Molecular Brain Research 114 123-131. (doi:10.1016/S0169-328X(03)00162-1)
34. Jeannotte L, Trifiro MA, Plante RK, Chamberland M & Drouin J 1987 Tissue-specific activity of the pro-opioomelanocortin gene promoter. Molecular and Cellular Biology 7 4058-4064. (doi:10.1128/ MCB.7.11.4058).
35. Jordan S, Lidhar K, Korbonits M, Lowe DG & Grossman AB 2000 Cyclin D and cyclin E expression in normal and adenomatous pituitary. European Journal of Endocrinology 143 R1-R6. (doi:10.1530/ eje.0.143R001).
36. Kitamura K, Miura H, Miyagawa-Tomita S, Yanazawa M, Katoh-Fukui Y, Suzuki R, Ohuchi H, Suehiro A, Motegi Y, Nakahara Y, et al. 1999 Mouse Pitx2 deficiency leads to anomalies of the ventral body wall, heart, extra-and periocular mesoderm and right pulmonary isomerism. Development 126 5749-5758.
37. Kovalovsky D, Refojo D, Liberman AC, Hochbaum D, Pereda MP, Coso OA, Stalla GK, Holsboer F & Arzt E 2002 Activation and induction of NUR77/NURR1 in corticotrophs by CRH/cAMP: involvement of calcium, protein kinase A, and MAPK pathways. Molecular Endocrinology 16 1638-1651. (doi:10.1210/mend.16.7.0863)
38. L'Honoré A, Coulon V, Marcil A, Lebel M, Lafrance-Vanasse J, Gage PJ, Camper SA & Drouin J 2007 Sequential expression and redundancy of Pitx2 and Pitx3 genes during muscle development. Developmental Biology 307 421-433. (doi:10.1016/j.ydbio.2007.04.034)
39. L'Honoré A, Ouimette JF, Lavertu Jolin M & Drouin J 2010 Pitx2 defines alternate pathways acting through MyoD during limb and somitic myogenesis. Development 137 3847-3856. (doi:10.1242/ dev.053421).
40. L'Honore A, Commere PH, Ouimette JF, Montarras D, Drouin J & Buckingham M 2014 Redox regulation by Pitx2 and Pitx3 is critical for fetal myogenesis. Developmental Cell 29 392-405. (doi:10.1016/j. devcel.2014.04.006).
41. Lam DD, de Souza FS, Nasif S, Yamashita M, Lopez-Leal R, Otero-Corchon V, Meece K, Sampath H, Mercer AJ, Wardlaw SL, et al. 2015 Partially redundant enhancers cooperatively maintain Mammalian pomc expression above a critical functional threshold. PLoS Genetics 11 e1004935. (doi:10.1371/journal.pgen.1004935)
42. Lamberts SWJ 2002 Glucocorticoid receptors and Cushing's disease. Molecular and Cellular Endocrinology 197 69-72. (doi:10.1016/S0303-7207(02)00280-0).
43. Lamolet B, Pulichino AM, Lamonerie T, Gauthier Y, Brue T, Enjalbert A & Drouin J 2001 A pituitary cell-restricted T-box factor, Tpit, activates POMC transcription in cooperation with Pitx homeoproteins. Cell 104 849-859. (doi:10.1016/S0092-8674(01)00282-3).
44. Lamolet B, Poulin G, Chu K, Guillemot F, Tsai MJ & Drouin J 2004 Tpit-independent function of NeuroD1(BETA2) in pituitary corticotroph differentiation. Molecular Endocrinology 18 995-1003. (doi:10.1210/me.2003-0127)
45. Lamonerie T, Tremblay JJ, Lanctôt C, Therrien M, Gauthier Y & Drouin J 1996 PTX1, a bicoid-related homeobox transcription factor involved in transcription of pro-opiomelanocortin (POMC) gene. Genes & Development 10 1284-1295. (doi:10.1101/gad.10.10.1284)
46. Lanctôt C, Lamolet B & Drouin J 1997 The bicoid-related homeoprotein Ptx1 defines the most anterior domain of the embryo and differentiates posterior from anterior lateral mesoderm. Development 124 2807-2817.
47. Lanctôt C, Gauthier Y & Drouin J 1999a Pituitary homeobox 1 (Ptx1) is differentially expressed during pituitary development. Endocrinology 140 1416-1422. (doi:10.1210/endo.140.3.6549)
48. Lanctôt C, Moreau A, Chamberland M, Tremblay ML & Drouin J 1999b Hindlimb patterning and mandible development require the Ptx1 gene. Development 126 1805-1810.
49. Langlais D, Couture C, Sylvain-Drolet G & Drouin J 2011 A pituitaryspecific enhancer of the POMC gene with preferential activity in corticotrope cells. Molecular Endocrinology 25 348-359. (doi:10.1210/ me.2010-0422).
50. Langlais D, Couture C & Drouin J 2012 The Stat3/GR interaction code: predictive value of direct/indirect DNA recruitment for transcription outcome. Molecular Cell 47 38-49. (doi:10.1016/j.molcel.2012.04.021)
51. Lavoie PL, Budry L, Balsalobre A & Drouin J 2008 Developmental dependence on NurRE and EboxNeuro for expression of pituitary POMC. Molecular Endocrinology 22 1647-1657. (doi:10.1210/ me.2007-0567).
52. Liddle GW 1960 Tests of pituitary-adrenal suppressibility in the diagnosis of Cushing's syndrome. Journal of Clinical Endocrinology & Metabolism 20 1539-1560. (doi:10.1210/jcem-20-12-1539)
53. Lidhar K, Korbonits M, Jordan S, Khalimova Z, Kaltsas G, Lu X, Clayton RN, Jenkins PJ, Monson JP, Besser GM, et al. 1999 Low expression of the cell cycle inhibitor p27Kip1 in normal corticotroph cells, corticotroph tumors, and malignant pituitary tumors. Journal of Clinical Endocrinology & Metabolism 84 3823-3830. (doi:10.1210/ jcem.84.10.6066).
54. Lin CR, Kioussi C, O'Connell S, Briata P, Szeto D, Liu R, Izpisua Belmonte JC & Rosenfeld MG 1999 Pitx2 regulates lung asymmetry, cardiac positioning and pituitary and tooth morphegenesis. Nature 401 279-282. (doi:10.1038/45803)
55. Lu MF, Pressman C, Dyer R, Johnson RL & Martin JF 1999 Function of Rieger syndrome gene in left-right asymmetry and craniofacial development. Nature 401 276-278. (doi:10.1038/45797)
56. Maira MH, Martens C, Philips A & Drouin J 1999 Heterodimerization between members of the Nur subfamily of orphan nuclear receptors as a novel mechanism for gene activation. Molecular and Cellular Biology 19 7549-7557. (doi:10.1128/MCB.19.11.7549)
57. Maira MH, Couture C, Le Martelot G, Pulichino AM, Bilodeau S & Drouin J 2003a The T-box factor Tpit recruits SRC/p160 coactivators and mediates hormone action. Journal of Biological Chemistry 278 46523-46532. (doi:10.1074/jbc.M305626200)
58. Maira MH, Martens C, Batsche E, Gauthier Y & Drouin J 2003b Dimerspecific potentiation of NGFI-B (Nur77) transcriptional activity by the protein kinase A pathway and AF-1-dependent coactivator recruitment. Molecular and Cellular Biology 23 763-776. (doi:10.1128/ MCB.23.3.763-776.2003).
59. Martens C, Bilodeau S, Maira M, Gauthier Y & Drouin J 2005 Protein: protein interactions and transcriptional antagonism between the subfamily of NGFI-B/Nur77 orphan nuclear receptors and glucocorticoid receptor. Molecular Endocrinology 19 885-897. (doi:10.1210/me.2004-0333)
60. Mountjoy KG 2010 Functions for pro-opiomelanocortin-derived peptides in obesity and diabetes. Biochemical Journal 428 305-324. (doi:10.1042/BJ20091957)
61. Nasif S, de Souza FS, Gonzalez LE, Yamashita M, Orquera DP, Low MJ & Rubinstein M 2015 Islet 1 specifies the identity of hypothalamic melanocortin neurons and is critical for normal food intake and adiposity in adulthood. PNAS 112 E1861-E1870. (doi:10.1073/pnas.1500672112)
62. Nudi M, Ouimette JF & Drouin J 2005 Bone morphogenic protein (Smad)-mediated repression of proopiomelanocortin transcription by interference with Pitx/Tpit activity. Molecular Endocrinology 19 1329-1342. (doi:10.1210/me.2004-0425)
63. Nunes I, Tovmasian LT, Silva RM, Burke RE & Goff SP 2003 Pitx3 is required for development of substantia nigra dopaminergic neurons. PNAS 100 4245-4250. (doi:10.1073/pnas.0230529100)
64. Padilla SL, Carmody JS & Zeltser LM 2010 Pomc-expressing progenitors give rise to antagonistic neuronal populations in hypothalamic feeding circuits. Nature Medicine 16 403-405. (doi:10.1038/ nm.2126).
65. Perez-Rivas LG, Theodoropoulou M, Ferrau F, Nusser C, Kawaguchi K, Stratakis CA, Rueda Faucz F, Wildemberg LE, Assie G, Beschorner R, et al. 2015 The gene of the ubiquitin-specific protease 8 is frequently mutated in adenomas causing Cushing's disease. Journal of Clinical Endocrinology & Metabolism 100 E997-E1004. (doi:10.1210/jc.2015-1453).
66. Philips A, Lesage S, Gingras R, Maira MH, Gauthier Y, Hugo P & Drouin J 1997a Novel dimeric Nur77 signaling mechanisms in endocrine and lymphoid cells. Molecular and Cellular Biology 17 5946-5951. (doi:10.1128/MCB.17.10.5946)
67. Philips A, Maira MH, Mullick A, Chamberland M, Lesage S, Hugo P & Drouin J 1997b Antagonism between Nur77 and glucocorticoid receptor for control of transcription. Molecular and Cellular Biology 17 5952-5959. (doi:10.1128/MCB.17.10.5952)
68. Poulin G, Turgeon B & Drouin J 1997 NeuroD1/BETA2 contributes to cell-specific transcription of the POMC gene. Molecular and Cellular Biology 17 6673-6682. (doi:10.1128/MCB.17.11.6673)
69. Poulin G, Lebel M, Chamberland M, Paradis FW & Drouin J 2000 Specific protein: protein interaction between basic Helix-Loop-Helix transcription factors and homeoproteins of the Pitx family. Molecular and Cellular Biology 20 4826-4837. (doi:10.1128/MCB.20.13.4826-4837.2000).
70. Pulichino AM, Vallette-Kasic S, Couture C, Gauthier Y, Brue T, David M, Malpuech G, Deal C, Van Vliet G, De Vroede M, et al. 2003a Human and mouse Tpit gene mutations cause early onset pituitary ACTH deficiency. Genes & Development 17 711-716. (doi:10.1101/ gad.1065603).
71. Pulichino AM, Vallette-Kasic S, Tsai JP, Couture C, Gauthier Y & Drouin J 2003b Tpit determines alternate fates during pituitary cell differentiation. Genes & Development 17 738-747. (doi:10.1101/ gad.1065703).
72. Quentien MH, Delemer B, Papadimitriou DT, Souchon PF, Jaussaud R, Pagnier A, Munzer M, Jullien N, Reynaud R, Galon-Faure N, et al. 2012 Deficit in anterior pituitary function and variable immune deficiency (DAVID) in children presenting with adrenocorticotropin deficiency and severe infections. Journal of Clinical Endocrinology & Metabolism 97 E121-E128. (doi:10.1210/jc.2011-0407)
73. Rambaud J, Desroches J, Balsalobre A & Drouin J 2009 TIF1beta/KAP-1 is a coactivator of the orphan nuclear receptor NGFI-B/Nur77. Journal of Biological Chemistry 284 14147-14156. (doi:10.1074/jbc. M809023200).
74. Ray DW, Ren SG & Melmed S 1996 Leukemia inhibitory factor (LIF) stimulates proopiomelanocortin (POMC) expression in a corticotroph cell line. Role of STAT pathway. Journal of Clinical Investigation 97 1852-1859. (doi:10.1172/JCI118615)
75. Reincke M, Sbiera S, Hayakawa A, Theodoropoulou M, Osswald A, Beuschlein F, Meitinger T, Mizuno-Yamasaki E, Kawaguchi K, Saeki Y, et al. 2015 Mutations in the deubiquitinase gene USP8 cause Cushing's disease. Nature Genetics 47 31-38. (doi:10.1038/ng.3166)
76. Riebold M, Kozany C, Freiburger L, Sattler M, Buchfelder M, Hausch F, Stalla GK & Paez-Pereda M 2015 A C-terminal HSP90 inhibitor restores glucocorticoid sensitivity and relieves a mouse allograft model of Cushing disease. Nature Medicine 21 276-280. (doi:10.1038/nm.3776)
77. Roussel-Gervais A, Bilodeau S, Vallette S, Berthelet F, Lacroix A, Figarella-Branger D, Brue T & Drouin J 2010 Cooperation between cyclin E and p27Kip1 in pituitary tumorigenesis. Molecular Endocrinology 24 1835-1845. (doi:10.1210/me.2010-0091)
78. Roussel-Gervais A, Couture C, Langlais D, Takayasu S, Balsalobre A, Rueda BR, Zukerberg LR, Figarella-Branger D, Brue T & Drouin J 2016 The Cables1 gene in glucocorticoid regulation of pituitary corticotrope growth and Cushing disease. Journal of Clinical Endocrinology & Metabolism 101 513-522. (doi:10.1210/jc.2015-3324)
79. Rubinstein M, Mortrud M, Liu B & Low MJ 1993 Rat and mouse proopiomelanocortin gene sequences target tissue-specific expression to the pituitary gland but not to the hypothalamus of transgenic mice. Neuroendocrinology 58 373-380. (doi:10.1159/000126566)
80. Semina EV, Reiter RS & Murray J 1997 Isolation of a new homeobox gene belonging to the Pitx/Rieg family: expression during lens development and mapping to the aphakia region on mouse chromosome 19. Human Molecular Genetics 6 2109-2116. (doi:10.1093/hmg/6.12.2109)
81. Semina EV, Ferrell RE, Mintz-Hittner HA, Bitoun P, Alward WLM, Reiter RS, Funkhauser C, Daack-Hirsch S & Murray JC 1998 A novel homeobox gene PITX3 is mutated in families with autosomal-dominant cataracts and ASMD. Nature Genetics 19 167-170. (doi:10.1038/527)
82. Smidt MP, van Schaick HS, Lanctôt C, Tremblay JJ, Cox JJ, van der Kleij AA, Wolterink G, Drouin J & Burbach JP 1997 A homeodomain gene Ptx3 has highly restricted brain expression in mesencephalic dopaminergic neurons. PNAS 94 13305-13310. (doi:10.1073/pnas.94.24.13305)
83. Szeto DP, Rodriguez-Esteban C, Ryan AK, O'Connell SM, Liu F, Kioussi C, Gleiberman AS, Izpisua-Belmonte JC & Rosenfeld MG 1999 Role of the Bicoid-related homeodomain factor Pitx1 in specifying hindlimb morphogenesis and pituitary development. Genes & Development 13 484-494. (doi:10.1101/gad.13.4.484)
84. Takayasu S, Iwasaki Y, Nigawara T, Asai M, Yoshida M, Kageyama K & Suda T 2010 Involvement of nuclear factor-kB and Nurr-1 in cytokine-induced transcription of proopiomelanocortin gene in AtT20 corticotroph cells. Neuroimmunomodulation 17 88-96. (doi:10.1159/000258691)
85. Therrien M & Drouin J 1991 Pituitary pro-opiomelanocortin gene expression requires synergistic interactions of several regulatory elements. Molecular and Cellular Biology 11 3492-3503. (doi:10.1128/ MCB.11.7.3492).
86. Therrien M & Drouin J 1993 Cell-specific helix-loop-helix factor required for pituitary expression of the pro-opiomelanocortin gene. Molecular and Cellular Biology 13 2342-2353. (doi:10.1128/MCB.13.4.2342)
87. Treisman J, Gonczy P, Vashishtha M, Harris E & Desplan C 1989 A single amino acid can determine the DNA binding specificity of homeodomain proteins. Cell 59 553-562. (doi:10.1016/0092-8674(89)90038-X)
88. Tremblay JJ & Drouin J 1999 Egr-1 is a downstream effector of GnRH and synergizes by direct interaction with Ptx1 and SF-1 to enhance luteinizing hormone? gene transcription. Molecular and Cellular Biology 19 2567-2576. (doi:10.1128/MCB.19.4.2567)
89. Tremblay Y, Tretjakoff I, Peterson A, Antakly T, Zhang CX & Drouin J 1988 Pituitary-specific expression and glucocorticoid regulation of proopiomelanocortin fusion gene in transgenic mice. PNAS 85 8890-8894. (doi:10.1073/pnas.85.23.8890)
90. Tremblay JJ, Lanctôt C & Drouin J 1998 The pan-pituitary activator of transcription, Ptx-1 (pituitary homeobox1), acts in synergy with SF-1 and Pit1 and is an upstream regulator of the Lim-homeodomain gene Lim3/Lhx3. Molecular Endocrinology 12 428-441. (doi:10.1210/ mend.12.3.0073).
91. Tremblay JJ, Marcil A, Gauthier Y & Drouin J 1999 Ptx1 regulates SF-1 activity by an interaction that mimics the role of the ligand-binding domain. EMBO Journal 18 3431-3441. (doi:10.1093/emboj/18.12.3431)
92. Tremblay JJ, Goodyer CG & Drouin J 2000 Transcriptional properties of Ptx1 and Ptx2 isoforms. Neuroendocrinology 71 277-286. (doi:10.1159/000054547)
93. Vallette-Kasic S, Figarella-Branger D, Grino M, Pulichino AM, Dufour H, Grisoli F, Enjalbert A, Drouin J & Brue T 2003 Differential regulation of proopiomelanocortin and pituitary-restricted transcription factor (TPIT), a new marker of normal and adenomatous human corticotrophs. Journal of Clinical Endocrinology & Metabolism 88 3050-3056. (doi:10.1210/jc.2002-021934)
94. Vallette-Kasic S, Brue T, Pulichino AM, Gueydan M, Barlier A, David M, Nicolino M, Malpuech G, Déchelotte P, Deal C, et al. 2005 Congenital isolated adrenocorticotropin deficiency: an underestimated cause of neonatal death, explained by TPIT gene mutations. Journal of Clinical Endocrinology & Metabolism 90 1323-1331. (doi:10.1210/jc.2004-1300)
95. Vallette-Kasic S, Couture C, Balsalobre A, Gauthier Y, Metherell LA, Dattani M & Drouin J 2007 The TPIT gene mutation M86R associated with isolated ACTH deficiency interferes in protein: protein interactions. Journal of Clinical Endocrinology & Metabolism 92 3991-3999. (doi:10.1210/jc.2007-0284)
96. van den Munckhof P, Luk KC, Sainte-Marie L, Montgomery J, Blanchet PJ, Sadikot AF & Drouin J 2003 Pitx3 is required for motor activity and for survival of a subset of midbrain dopaminergic neurons. Development 130 2535-2542. (doi:10.1242/dev.00464)
97. van den Munckhof P, Gilbert F, Chamberland M, Lévesque D & Drouin J 2006 Striatal neuroadaptation and rescue of locomotor deficit by L-dopa in aphakia mice, a model of Parkinson's disease. Journal of Neurochemistry 96 160-170. (doi:10.1111/j.1471-4159.2005.03522.x)
98. Yang G, Lim CY, Li C, Xiao X, Radda GK, Li C, Cao X & Han W 2009 FoxO1 inhibits leptin regulation of pro-opiomelanocortin promoter activity by blocking STAT3 interaction with specificity protein 1. Journal of Biological Chemistry 284 3719-3727. (doi:10.1074/jbc.M804965200)
99. Young JI, Otero V, Cerdan MG, Falzone TL, Chan EC, Low MJ & Rubinstein M 1998 Authentic cell-specific and developmentally regulated expression of pro-opiomelanocortin genomic fragments in hypothalamic and hindbrain neurons of transgenic mice. Journal of Neuroscience 18 6631-6640.
100. Zhang N, Lin JK, Chen J, Liu XF, Liu JL, Luo HS, Li YQ & Cui S 2013 MicroRNA 375 mediates the signaling pathway of corticotropinreleasing factor (CRF) regulating pro-opiomelanocortin (POMC) expression by targeting mitogen-activated protein kinase 8. Journal of Biological Chemistry 288 10361-10373. (doi:10.1074/jbc.M112.425504)
101. Zhang F, Tanasa B, Merkurjev D, Lin C, Song X, Li W, Tan Y, Liu Z, Zhang J, Ohgi KA, et al. 2015 Enhancer-bound LDB1 regulates a corticotrope promoter-pausing repression program. PNAS 112 1380-1385. (doi:10.1210/jc.2008-1102)